Evidence map›Paper›PMID 33093437›Full record

ArticleAnnals of transplantation2020

Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.

Reza Nabavizadeh, Anika A Noorali, Salima S Makhani, Gordon Hong, Sarah Holzman, Dattatraya H Patil, Frances Y Kim, Paul L Tso, Nicole A Turgeon, Kenneth Ogan and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Reza NabavizadehDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Anika A NooraliSchool of Medicine, Mercer University, Macon, GA, USA.
Salima S MakhaniSchool of Medicine, Mercer University, Macon, GA, USA.
Gordon HongCollege of Medicine, Northeast Ohio Medical University, Rootstown, OH, USA.
Sarah HolzmanDepartment of Urology, University of California Irvine and Children's Hospital, Orange, CA, USA.
Dattatraya H PatilDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Frances Y KimDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Paul L TsoDepartment of Transplant Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Nicole A TurgeonDepartment of Transplant Surgery, University of Texas Dell Medical School, Austin, TX, USA.
Kenneth OganDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Viraj A MasterDepartment of Urology, Emory University School of Medicine, Atlanta, GA, USA.
Emory University · USMercer University · USChildren's Hospital of Orange County · USNortheast Ohio Medical University · USThe University of Texas at Austin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The treatment of complex tumors in non-functioning renal transplants requiring surgical extirpation is challenging. Here, we report the largest series of patients who underwent transplant radical nephrectomy for renal cell carcinoma (RCC) and transplant radical nephroureterectomy for urothelial cell carcinoma (UCC) in their transplanted kidneys. MATERIAL AND METHODS From 2004 to 2018, 10 patients underwent transplant radical nephrectomy (7 patients) and nephroureterectomy (3 patients). Retrospective analyses, in terms of complications, oncological recurrence, and survival, of peri-operative and long-term outcomes, were performed. RESULTS Out of the 10 patients, 7 had RCC and 3 had UCC. No intraoperative mortality occurred. Three patients presented with Clavien-Dindo grade IIIa or greater within 30 days of surgery. Two patients died within 60 days of surgery, both due to vascular events: one due to myocardial infarction and one due to stroke. Two other patients died: one after 2.9 years, due to myocardial infarction, and the other after 6 years, due to unknown reasons. At the 7-year follow-up, there was a 60% overall survival rate. For all patients, average survival post-nephrectomy was approximately 4.5 years, including the 6 living patients and 4 deceased patients. Importantly, there was no observed cancer recurrence. CONCLUSIONS This study reports outcomes of the largest series of transplant radical nephrectomy and nephroureterectomy for malignancies of renal allografts. In the optimized setting, extirpative surgeries appear safe, with favorable long-term oncological and survival outcomes.

Indexed as

Kidney NeoplasmsNephrectomyNephroureterectomyUreteral NeoplasmsFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalRetrospective StudiesSurvival AnalysisTreatment Outcome

Identifiers

PMID33093437
PMCPMC7590527
OpenAlexW3093970687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.